John A. Salmon
John A. Salmon publishes mostly in Pharmacology, Biochemistry and Molecular Biology, on topics such as Inflammatory mediators and NSAID effects, Eicosanoids and Hypertension Pharmacology and Estrogen and related hormone effects.
- World rank
- #272,864 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #24,504 of 367,258
- Works
- 106
- Citations
- 5.7k
- Citations per work
- 53.9
What does John A. Salmon research?
John A. Salmon's work is mostly in Medicine (26%), Biochemistry, Genetics and Molecular Biology (25%), Chemistry (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4744.1%
- Health Sciences2725.8%
- Medicine2725.8%
- Life Sciences2725.1%
- Physical Sciences55.0%
- Chemistry55.0%
- 1Pharmacology20% of their works
- 2Biochemistry14% of their works
- 3Molecular Biology6% of their works
- 4Physiology6% of their works
- 5Genetics5% of their works
- 6Organic Chemistry5% of their works
Research topics
- Inflammatory mediators and NSAID effects
- Eicosanoids and Hypertension Pharmacology
- Estrogen and related hormone effects
- Asthma and respiratory diseases
- Fatty Acid Research and Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Peroxisome Proliferator-Activated Receptors
- Neuropeptides and Animal Physiology
Which keywords describe John A. Salmon's research?
The keywords of their largest research topics: Inflammation, Cancer, Cyclooxygenase-2 Inhibitors, Metabolism, Arachidonic Acid, Epoxyeicosatrienoic Acids, Nuclear Receptors and Transcriptional Regulation.
- Receptors
- PPARs
- Clopidogrel
- Omega-3 Fatty Acids
- Receptor
- Asthma
- Transcriptional Regulation
- Epoxyeicosatrienoic Acids
- Metabolism
- Cancer
- Inflammation
- Cyclooxygenase-2 Inhibitors
- Arachidonic Acid
- Nuclear Receptors
- Allergic Diseases
- Estrogen
- Cardiovascular Disease
- Aspirin
- Neuropeptides
- Peroxisome Proliferator-Activated Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Inflammation1265 topics
- Cancer571 topic
- Cyclooxygenase-2 Inhibitors571 topic
- Metabolism472 topics
- Arachidonic Acid421 topic
- Epoxyeicosatrienoic Acids421 topic
- Nuclear Receptors182 topics
- Transcriptional Regulation182 topics
- Allergic Diseases131 topic
- Asthma131 topic
- Estrogen131 topic
- Receptor131 topic
- Cardiovascular Disease91 topic
- Omega-3 Fatty Acids91 topic
- Aspirin71 topic
- Clopidogrel71 topic
- Neuropeptides51 topic
- PPARs51 topic
- Peroxisome Proliferator-Activated Receptors51 topic
- Receptors51 topic
Where does John A. Salmon work?
John A. Salmon's main affiliation in the publication record is Wellcome Trust, United Kingdom.
How many publications and citations does John A. Salmon have?
OpenAlex counts 106 works and 5,714 citations for John A. Salmon, an h-index of 39, ranking #272,864 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John A. Salmon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.